We are live on ! Find out more
PFNX

Pfenex Inc.
PFNX

Delisted

PFNX was delisted on the 30th of September, 2020.

85 hedge funds and large institutions have $223M invested in Pfenex Inc. in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

59% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 27

2% more call options, than puts

Call options by funds: $554K | Put options by funds: $541K

10% less capital invested

Capital invested by funds: $246M → $223M (-$23.5M)

13% less funds holding

Funds holding: 9885 (-13)

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

Holders
85
Holders Change
-13
Holders Change %
-13.27%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
8
Increased
43
Reduced
27
Closed
21
Calls
$554K
Puts
$541K
Net Calls
+$13K
Net Calls Change
+$19K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
51
Millennium Management
New York
$243K -$1.41M -188,115 -87%
D.E. Shaw & Co
52
D.E. Shaw & Co
New York
$226K -$13.4K -1,789 -6%
BFM
53
Boothbay Fund Management
New York
$202K +$41.8K +5,584 +30%
BIM
54
Bogle Investment Management
Massachusetts
$198K -$462K -61,731 -72%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$197K
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$183K +$17.3K +2,308 +12%
Baird Financial Group
57
Baird Financial Group
Wisconsin
$180K +$18.2K +2,436 +13%
Man Group
58
Man Group
United Kingdom
$177K -$76.6K -10,233 -33%
AIG
59
American International Group
New York
$176K +$25.6K +3,423 +19%
UBS Group
60
UBS Group
Switzerland
$161K -$27.6K -3,693 -16%
Barclays
61
Barclays
United Kingdom
$159K +$66.4K +8,874 +88%
SG Americas Securities
62
SG Americas Securities
New York
$157K +$54.7K +7,316 +64%
DIM
63
Delta Investment Management
California
$152K -$74.8K -10,000 -35%
Deutsche Bank
64
Deutsche Bank
Germany
$147K +$54.1K +7,237 +70%
MIM
65
MetLife Investment Management
New Jersey
$143K +$12.9K +1,720 +11%
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$137K +$123K +16,380 New
RC
67
RBF Capital
California
$129K +$116K +15,456 New
Creative Planning
68
Creative Planning
Kansas
$119K +$107K +14,265 New
Bank of America
69
Bank of America
North Carolina
$111K +$14.9K +1,985 +18%
FPC
70
Falcon Point Capital
California
$110K -$261K -34,941 -73%
TRCT
71
Tower Research Capital (TRC)
New York
$100K +$53.3K +7,124 +146%
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$98.7K +$7.97K +1,065 +10%
Lazard Asset Management
73
Lazard Asset Management
New York
$54K -$6.08K -813 -11%
Legal & General Group
74
Legal & General Group
United Kingdom
$47K +$4.59K +614 +12%
Citigroup
75
Citigroup
New York
$39K -$36.1K -4,823 -51%

PFNX Hedge Fund Activity: Q2 2020 in Review

85 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pfenex Inc. (PFNX) for Q2 2020, worth a combined $223M — down 9.5% from $246M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of PFNX and 8 opened new positions — a net loss of 13 holders — while 27 trimmed existing stakes and 43 added.

The largest buyer was RK Capital Management (Colorado), adding an estimated $3.54M. The largest seller was OrbiMed, exiting entirely with an estimated $11.5M sold.

  • 85 institutional investors held Pfenex Inc. (PFNX) as of Q2 2020, down from 98 in Q1 2020.
  • Funds reported $223M of Pfenex Inc. stock for Q2 2020, down 9.5% quarter-over-quarter.
  • 8 funds opened new Pfenex Inc. positions in Q2 2020 and 21 closed out, a net change of -13 holders.
  • The largest Pfenex Inc. buyer in Q2 2020 was RK Capital Management (Colorado), an estimated $3.54M added.
  • The largest Pfenex Inc. seller in Q2 2020 was OrbiMed, an estimated $11.5M sold.

Based on aggregated 13F filings for Q2 2020.